Keros Therapeutics Price Target Cut to $44.00/Share From $77.00 by Scotiabank

Keros Therapeutics的目標股價從77.00美元下調至44.00美元，調整由斯科舍銀行進行。

道瓊斯 · 13:56 · 評級/大行評級

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.